JP2018033454A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018033454A5 JP2018033454A5 JP2017161826A JP2017161826A JP2018033454A5 JP 2018033454 A5 JP2018033454 A5 JP 2018033454A5 JP 2017161826 A JP2017161826 A JP 2017161826A JP 2017161826 A JP2017161826 A JP 2017161826A JP 2018033454 A5 JP2018033454 A5 JP 2018033454A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- humanized anti
- amino acid
- acid sequence
- htfr antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021200504A JP7232889B2 (ja) | 2016-08-25 | 2021-12-10 | 抗体融合蛋白質の製造方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016164901 | 2016-08-25 | ||
| JP2016164901 | 2016-08-25 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200504A Division JP7232889B2 (ja) | 2016-08-25 | 2021-12-10 | 抗体融合蛋白質の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018033454A JP2018033454A (ja) | 2018-03-08 |
| JP2018033454A5 true JP2018033454A5 (enExample) | 2020-06-25 |
| JP6993814B2 JP6993814B2 (ja) | 2022-01-14 |
Family
ID=61246169
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017161826A Active JP6993814B2 (ja) | 2016-08-25 | 2017-08-25 | 抗体融合蛋白質の製造方法 |
| JP2021200504A Active JP7232889B2 (ja) | 2016-08-25 | 2021-12-10 | 抗体融合蛋白質の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021200504A Active JP7232889B2 (ja) | 2016-08-25 | 2021-12-10 | 抗体融合蛋白質の製造方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11512135B2 (enExample) |
| EP (1) | EP3505538B1 (enExample) |
| JP (2) | JP6993814B2 (enExample) |
| KR (1) | KR102318480B1 (enExample) |
| CN (1) | CN109641971B (enExample) |
| AU (1) | AU2017316955B2 (enExample) |
| BR (1) | BR112019003622A2 (enExample) |
| CA (1) | CA3034589A1 (enExample) |
| MX (1) | MX389073B (enExample) |
| SG (1) | SG11201901495YA (enExample) |
| WO (1) | WO2018038243A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI769982B (zh) | 2015-06-24 | 2022-07-11 | 日商Ｊｃｒ製藥股份有限公司 | 通過血腦障壁之抗人類運鐵蛋白受體抗體 |
| CA2990565A1 (en) | 2015-06-24 | 2016-12-29 | Jcr Pharmaceuticals Co., Ltd. | Fusion protein containing bdnf and anti-human transferrin receptor antibody |
| CN109983031B (zh) | 2016-12-26 | 2022-11-25 | Jcr制药股份有限公司 | 通过血脑屏障的新的抗人转铁蛋白受体抗体 |
| KR102573622B1 (ko) | 2016-12-26 | 2023-08-31 | 제이씨알 파마 가부시키가이샤 | Bdnf를 포함하는 융합 단백질 |
| CN111278453A (zh) | 2017-09-07 | 2020-06-12 | Jcr制药股份有限公司 | 水性药物组合物 |
| MA50746A (fr) | 2017-10-02 | 2020-08-12 | Denali Therapeutics Inc | Protéines de fusion comprenant des enzymes d'enzymothérapie substitutive |
| US20210038739A1 (en) * | 2018-02-05 | 2021-02-11 | Jcr Pharmaceuticals Co., Ltd. | Method for Delivering Drug to Muscle |
| EP3560945A1 (en) * | 2018-04-27 | 2019-10-30 | F. Hoffmann-La Roche AG | Methods for purification of polypeptides using polysorbates |
| WO2019224660A1 (ja) * | 2018-05-24 | 2019-11-28 | ＨＯＹＡ Ｔｅｃｈｎｏｓｕｒｇｉｃａｌ株式会社 | 吸着剤の生産方法 |
| KR102692543B1 (ko) * | 2018-10-26 | 2024-08-07 | 재단법인 목암생명과학연구소 | Ids를 포함하는 융합 단백질 및 이의 용도 |
| CR20230178A (es) | 2020-10-14 | 2023-07-26 | Denali Therapeutics Inc | Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas |
| WO2022135457A1 (zh) * | 2020-12-23 | 2022-06-30 | 广东菲鹏制药股份有限公司 | 一种抗pd-l1抗体及其应用 |
| US20240148866A1 (en) * | 2021-02-11 | 2024-05-09 | Denali Therapeutics Inc. | Anti-transferrin receptor fusion proteins and methods of use thereof |
| EP4299756A4 (en) | 2021-03-09 | 2025-03-12 | JCR Pharmaceuticals Co., Ltd. | METHOD FOR PRODUCING AN ANTIBODY LYSOSOMALIC ENZYMFUSION PROTEIN |
| AU2022426018A1 (en) * | 2021-12-28 | 2024-07-18 | Jcr Pharmaceuticals Co., Ltd. | Fusion protein of anti-transferrin receptor antibody and physiologically active protein for safe gene therapy |
| EP4534677A1 (en) * | 2022-07-08 | 2025-04-09 | JCR Pharmaceuticals Co., Ltd. | Nuecleic acid molecule, vector, recombinant cells, and drug for treating central nervous system diseases |
| WO2025137213A1 (en) | 2023-12-20 | 2025-06-26 | Denali Therapeutics Inc. | Fusion proteins comprising acid alpha-glucosidase enzymes and methods thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005024044A2 (en) * | 2003-09-05 | 2005-03-17 | Gtc Biotherapeutics, Inc. | Method for the production of fusion proteins in transgenic mammal milk |
| US20050100965A1 (en) | 2003-11-12 | 2005-05-12 | Tariq Ghayur | IL-18 binding proteins |
| NZ583153A (en) * | 2004-12-21 | 2011-06-30 | Centocor Ortho Biotech Inc | Anti-IL-12 antibodies, epitopes, compositions, methods and uses |
| WO2008068879A1 (en) | 2006-12-06 | 2008-06-12 | Jcr Pharmaceuticals Co., Ltd. | Method for production of human erythropoietin |
| JP5492563B2 (ja) * | 2006-12-12 | 2014-05-14 | バイオレクシス ファーマシューティカル コーポレーション | トランスフェリン融合タンパク質ライブラリー |
| JP2009273427A (ja) | 2008-05-16 | 2009-11-26 | Jcr Pharmaceuticals Co Ltd | 組換え体ヒトｆｓｈの製造方法 |
| US8058407B2 (en) | 2008-10-31 | 2011-11-15 | Wyeth Llc | Purification of acidic proteins using ceramic hydroxyapatite chromatography |
| ES2725200T3 (es) * | 2009-10-09 | 2019-09-20 | Armagen Inc | Métodos y composiciones para aumentar la actividad de iduronato 2-sulfatasa en el SNC |
| WO2012101671A1 (en) | 2011-01-25 | 2012-08-02 | Jcr Pharmaceuticals Co., Ltd. | Method for production of human recombinant iduronate 2-sulfatase |
| JP6018572B2 (ja) * | 2011-01-25 | 2016-11-02 | Ｊｃｒファーマ株式会社 | 組換えヒトイズロン酸−２−スルファターゼの製造方法 |
| EP2785837A4 (en) * | 2011-12-01 | 2015-07-01 | Angiochem Inc | TARGETED ENZYMATIC COMPOUNDS AND ITS USES |
| KR101380740B1 (ko) | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | 이듀로네이트-2-설파타제의 정제 |
| WO2014016873A1 (en) | 2012-07-26 | 2014-01-30 | Jcr Pharmaceuticals Co., Ltd. | Method for production of recombinant human alpha-galactosidase a |
| WO2015098989A1 (ja) | 2013-12-25 | 2015-07-02 | Ｊｃｒファーマ株式会社 | 血液脳関門を通過する新規抗トランスフェリン受容体抗体 |
| WO2016067944A1 (ja) | 2014-10-31 | 2016-05-06 | Ｊｃｒファーマ株式会社 | 組換えヒトＤＮａｓｅＩの製造方法 |
| WO2016116966A1 (en) | 2015-01-22 | 2016-07-28 | Jcr Pharmaceuticals Co., Ltd. | Method for purification of recombinant human alpha-galactosidase a from material containing contaminant host cell proteins |
-
2017
- 2017-08-25 CA CA3034589A patent/CA3034589A1/en active Pending
- 2017-08-25 WO PCT/JP2017/030470 patent/WO2018038243A1/ja not_active Ceased
- 2017-08-25 CN CN201780051299.5A patent/CN109641971B/zh active Active
- 2017-08-25 BR BR112019003622-9A patent/BR112019003622A2/pt unknown
- 2017-08-25 KR KR1020197007992A patent/KR102318480B1/ko active Active
- 2017-08-25 JP JP2017161826A patent/JP6993814B2/ja active Active
- 2017-08-25 US US16/327,982 patent/US11512135B2/en active Active
- 2017-08-25 MX MX2019002252A patent/MX389073B/es unknown
- 2017-08-25 AU AU2017316955A patent/AU2017316955B2/en active Active
- 2017-08-25 SG SG11201901495YA patent/SG11201901495YA/en unknown
- 2017-08-25 EP EP17843719.0A patent/EP3505538B1/en active Active
-
2021
- 2021-12-10 JP JP2021200504A patent/JP7232889B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018033454A5 (enExample) | ||
| JP2017176174A5 (enExample) | ||
| EA201200277A1 (ru) | Антитела против респираторного синцитиального вируса (pcb) и способы их применения | |
| JP2010515717A5 (enExample) | ||
| JP2019524645A5 (enExample) | ||
| JP2012507294A5 (enExample) | ||
| PE20090769A1 (es) | Proteinas de union a antigenos que se unen a par-2 | |
| JP2010502207A5 (enExample) | ||
| EA201291243A1 (ru) | Антитела против респираторно-синцитиального вируса (рсв) и способы их применения | |
| FI4074331T3 (fi) | Koostumuksia ja menetelmiä entsyymien internalisoimiseksi | |
| RU2015147300A (ru) | Гуманизированные антитела к cxcr5, их производные и их применение | |
| JP2012025766A5 (enExample) | ||
| JP2012025737A5 (enExample) | ||
| JP2005120106A5 (enExample) | ||
| JP2018530331A5 (enExample) | ||
| JP2012511913A5 (enExample) | ||
| JP2013172734A5 (enExample) | ||
| JP2010521147A5 (enExample) | ||
| JP2015212284A5 (enExample) | ||
| JP2015527366A5 (enExample) | ||
| WO2008114149A3 (en) | Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains | |
| RU2021134101A (ru) | Модифицированная j-цепь | |
| JP2018504907A5 (enExample) | ||
| WO2016207304A8 (en) | Monoclonal anti-il-1racp antibodies | |
| JP2018537415A5 (enExample) |